![Eoin McKinney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Eoin McKinney
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - |
Loopbaan van Eoin McKinney
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Eoin McKinney
- Ervaring